Regular Article
The Importance of SRS-1 Residues in Catalytic Specificity of Human Cytochrome P450 3A4

https://doi.org/10.1006/abbi.1999.1599Get rights and content

Abstract

The structural basis for the regioselective hydroxylation of Δ-4-3-ketosteroids by human CYP3A4 was investigated. Prior studies had suggested that the chemical reactivity of the allylic 6β-position might have a greater influence than steric constraints by the enzyme. Six highly conserved CYP3A residues from substrate recognition site 1 were examined by site-directed mutagenesis. F102A and A117L showed no spectrally detectable P450. V101G and T103A exhibited a wild-type progesterone metabolite profile. Of five mutants at residue N104, only N104D yielded holoenzyme and exhibited the same steroid metabolite profile as wild-type. Of four mutants at position S119 (A, L, T, V), the three hydrophobic ones produced 2β-OH rather than 6β-OH progesterone or testosterone as the major metabolite. Kinetic analysis showed S50 values similar to wild-type for S119A (progesterone) and S119V (testosterone), whereas the Vmax values for 2β-hydroxysteroid formation were increased in both cases. All four mutants exhibited an altered product profile for 7-hexoxycoumarin side-chain hydroxylation, whereas the stimulation of steroid hydroxylation by α-naphthoflavone was similar to the wild-type. The results indicate that the highly conserved residue S119 is a key determinant of CYP3A4 specificity and reveal an important role of the active site topology in steroid 6β-hydroxylation.

References (57)

  • H Yamazaki et al.

    Arch. Biochem. Biophys.

    (1997)
  • D.J Waxman et al.

    Arch. Biochem. Biophys.

    (1991)
  • A Koley et al.

    J. Biol. Chem.

    (1997)
  • O Gotoh

    J. Biol. Chem.

    (1992)
  • Y.-Q He et al.

    Arch. Biochem. Biophys.

    (1998)
  • Y.-Q He et al.

    Arch. Biochem. Biophys.

    (1996)
  • G.R Harlow et al.

    J. Biol. Chem.

    (1997)
  • T.L Domanski et al.

    Arch. Biochem. Biophys.

    (1998)
  • D.A Smith et al.

    Biochem. Pharmacol.

    (1992)
  • J.R Halpert et al.

    J. Biol. Chem.

    (1993)
  • T.L Poulos et al.

    J. Biol. Chem.

    (1985)
  • T Kronbach et al.

    J. Biol. Chem.

    (1991)
  • P Straub et al.

    J. Biol. Chem.

    (1993)
  • G.R Harlow et al.

    Arch. Biochem. Biophys.

    (1996)
  • G.H John et al.

    Arch. Biochem. Biophys.

    (1994)
  • P.J Ciaccio et al.

    Arch. Biochem. Biophys.

    (1989)
  • K.M Kedzie et al.

    J. Biol. Chem.

    (1991)
  • C.A Hasemann et al.

    Structure

    (1995)
  • C.A Hasemann et al.

    J. Mol. Biol.

    (1994)
  • R.O Juvonen et al.

    J. Biol. Chem.

    (1991)
  • S Graham-Lorence et al.

    J. Biol. Chem.

    (1997)
  • E.A Dierks et al.

    J. Biol. Chem.

    (1998)
  • D.R Nelson et al.

    Pharmacogenetics

    (1996)
  • F.P Guengerich

    FASEB J.

    (1992)
  • F.P Guengerich

    Chem. Res. Toxicol.

    (1990)
  • F.P Guengerich
  • K.E Thummel et al.

    Annu. Rev. Pharmacol. Toxicol.

    (1998)
  • T Kronbach et al.

    Mol. Pharmacol.

    (1989)
  • Cited by (65)

    • Pseudomonas aeruginosa cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE

      2022, Journal of Biological Chemistry
      Citation Excerpt :

      The absolute changes in absorbance deriving from a minimum of triplicate titrations were plotted as a function of ligand concentration and fitted to the one binding site model using the GraphPad Prism software (version 9.0.0, GraphPad software). Due to its high affinity for CYP168A1 and known activity as a substrate for other microbial CYP enzymes (53, 77), lauric acid was used as a model substrate for metabolism studies. For the hydroperoxide-driven catalysis, solutions of tBPH and CuOOH were freshly prepared in DMSO and incubated at different concentrations up to 120 min with 1 μM CYP168A1 and 10 μM lauric acid in 100 mM potassium phosphate, pH 7.4 (47).

    • Catalysis by allene oxide synthases (CYP74A and CYP74C): Alterations by the Phe/Leu mutation at the SRS-1 region

      2020, Phytochemistry
      Citation Excerpt :

      Some of them constitute the walls of the catalytic cavity, for instance, the I-helix (Werck-Reichhart and Feyereisen, 2000; Denisov et al., 2005; Bak et al., 2011). Furthermore, the experiments on site-directed mutagenesis revealed some primary determinants within the SRSs, which govern the type of catalysis (Roussel et al., 2000; Zawaira et al., 2008; Hughes et al., 2008; Lee et al., 2008; Toporkova et al., 2008, 2013, 2018a). One of these determinants, namely the Phe 137, was uncovered from the 3D-structure of Arabidopsis thaliana AOS (AtAOS, CYP74A1) (Lee et al., 2008).

    • In silico and in vitro analysis of genetic variants of the equine CYP3A94, CYP3A95 and CYP3A97 isoenzymes

      2019, Toxicology in Vitro
      Citation Excerpt :

      In fact, in vitro site-directed mutagenesis experiments on the human CYP3A4 indicated that amino acid 119 is implicated in the active site (Yano et al., 2004). Additionally, substitutions of Ser119Ala, Ser119Leu, Ser119Thr and Ser119Val exhibited significant lower 2β-hydroxylation activity (Roussel et al., 2000). Considering that in our homology model the Thr119 side chain is exposed to one of the substrate access/egress the channel to the heme group, which distance from the testosterone docked molecule is <5 Å in our homology model of CYP3A97, the double nature of Thr side chain indicates a possible contribution to reducing the rate of access/egress of testosterone/metabolites.

    View all citing articles on Scopus

    This work was supported by a Postdoctoral Fellowship from Pfizer Inc. (to F.R.), NIH Grants GM54995 and E303619, and Core Center Grant ES06676.

    2

    To whom correspondence should be addressed. Fax: (409) 772-9642. E-mail: [email protected].

    3

    F. R. and K. K. K. contributed equally to this work.

    View full text